288 related articles for article (PubMed ID: 18805667)
1. Multiresponse optimization of the properties of albendazole-chitosan microparticles.
Leonardi D; Lamas MC; Olivieri AC
J Pharm Biomed Anal; 2008 Nov; 48(3):802-7. PubMed ID: 18805667
[TBL] [Abstract][Full Text] [Related]
2. Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks.
Leonardi D; Salomón CJ; Lamas MC; Olivieri AC
Int J Pharm; 2009 Feb; 367(1-2):140-7. PubMed ID: 18938233
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ultrasonic atomization as a new approach to prepare ionically cross-linked chitosan microparticles.
Albertini B; Passerini N; Rodriguez L
J Pharm Pharmacol; 2005 Jul; 57(7):821-9. PubMed ID: 15969940
[TBL] [Abstract][Full Text] [Related]
4. Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.
Rai G; Jain SK; Agrawal S; Bhadra S; Pancholi SS; Agrawal GP
Pharmazie; 2005 Feb; 60(2):131-4. PubMed ID: 15739902
[TBL] [Abstract][Full Text] [Related]
5. Chitosan microparticles for the controlled delivery of fluoride.
Keegan GM; Smart JD; Ingram MJ; Barnes LM; Burnett GR; Rees GD
J Dent; 2012 Mar; 40(3):229-40. PubMed ID: 22212236
[TBL] [Abstract][Full Text] [Related]
6. Chitosan microparticles: influence of the gelation process on the release profile and oral bioavailability of albendazole, a class II compound.
Piccirilli GN; García A; Leonardi D; Mamprin ME; Bolmaro RE; Salomón CJ; Lamas MC
Drug Dev Ind Pharm; 2014 Nov; 40(11):1476-82. PubMed ID: 23971494
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process.
Wang LY; Gu YH; Zhou QZ; Ma GH; Wan YH; Su ZG
Colloids Surf B Biointerfaces; 2006 Jul; 50(2):126-35. PubMed ID: 16787743
[TBL] [Abstract][Full Text] [Related]
8. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
9. Preparation and preliminary characterization of concentric multi-walled chitosan microspheres.
Chang SJ; Niu GC; Kuo SM; Chen SF
J Biomed Mater Res A; 2007 Jun; 81(3):554-66. PubMed ID: 17133452
[TBL] [Abstract][Full Text] [Related]
10. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.
Lin CC; Fu CH
Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009
[TBL] [Abstract][Full Text] [Related]
11. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
[TBL] [Abstract][Full Text] [Related]
12. Ionization and solubility of chitosan solutions related to thermosensitive chitosan/glycerol-phosphate systems.
Filion D; Lavertu M; Buschmann MD
Biomacromolecules; 2007 Oct; 8(10):3224-34. PubMed ID: 17850110
[TBL] [Abstract][Full Text] [Related]
13. Effect of chitosan crosslinking on bitterness of artemether using response surface methodology.
Shah PP; Mashru RC; Thakkar AR; Badhan AC
J Pharm Pharmacol; 2008 Apr; 60(4):421-7. PubMed ID: 18380913
[TBL] [Abstract][Full Text] [Related]
14. Chitosan microparticle preparation for controlled drug release by response surface methodology.
Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
[TBL] [Abstract][Full Text] [Related]
15. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
Fan W; Yan W; Xu Z; Ni H
Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
[TBL] [Abstract][Full Text] [Related]
16. Physical gelation of chitosan in the presence of beta-glycerophosphate: the effect of temperature.
Cho J; Heuzey MC; Bégin A; Carreau PJ
Biomacromolecules; 2005; 6(6):3267-75. PubMed ID: 16283755
[TBL] [Abstract][Full Text] [Related]
17. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system.
Coppi G; Iannuccelli V
Int J Pharm; 2009 Feb; 367(1-2):127-32. PubMed ID: 18940240
[TBL] [Abstract][Full Text] [Related]
18. [The preparation and properties of Modified silk fibroin membranes by chitosan].
Liu L; Wu Z; Li P; Cai S; Chen X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):587-90. PubMed ID: 15357438
[TBL] [Abstract][Full Text] [Related]
19. Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: in vitro/in vivo evaluation.
Barakat NS; Almurshedi AS
J Microencapsul; 2011; 28(2):122-33. PubMed ID: 21110773
[TBL] [Abstract][Full Text] [Related]
20. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
